Thursday, January 28, 2010 4:34:57 PM
are you a therapist? you're absolutely right, i am impatient. I haven't always been however. I've been patient with this company for 9 years - no exaggeration. when am I going to be able to cash in on this thing??
"Just wait 'til next year, Charlie Brown. You'll see! Next year at this same time, I'll find the pumpkin patch that is real sincere and I'll sit in that pumpkin patch until the Great Pumpkin appears."
"Just wait 'til next year, Charlie Brown. You'll see! Next year at this same time, I'll find the pumpkin patch that is real sincere and I'll sit in that pumpkin patch until the Great Pumpkin appears."
Recent TENX News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/20/2026 09:05:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 10:55:54 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:26:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:31:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 09:08:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:56:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/12/2026 09:01:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:06:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 12:00:07 PM
- Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 10:19:02 PM
- Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/08/2026 08:05:00 PM
- Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer • GlobeNewswire Inc. • 05/04/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:19:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:17:37 PM
